Dry Eye Disease Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025

Jan 2018| TMR114A| Transparency

Report Highlights

Global Dry Eye Disease Market: Overview

Dry eye is an ocular disease caused due to insufficiency or lack of tears in eye. Tears made up of three layers viz. lipids, mucin and aqueous keep eye moist and lubricated. Lack of tears lead to redness, burning, sensing and pain in eye. Dry eye disease also known as Keratoconjuctivitis Sicca is a common phenomenon, which is estimated to have prevalence of 8% to 34% across the globe. Dry eye disease is categorized into evaporative dry eye disease and aqueous deficiency dry eye disease. Dry eye is a multifactorial disease, most of the currently approved prescription and currently approved dry eye treatment products are targeted to relief the signs and symptoms of dry eye disease. The choice of treatment depends upon the type and severity of dry eye disease.

Global Dry Eye Disease Market: Scope of the Study

This report on the dry eye disease market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year.

Market related factors such as technological developments, product innovation, expansion of healthcare infrastructure facilities around the world, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the dry eye disease market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, product development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

Global Dry Eye Disease Market: Key Segments

On the basis of products, the dry eye disease market is categorized into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogue and others. The anti-inflammatory drugs segment is further classified into cyclosporine, corticosteroids and lifitegrast. While the others segment include oral omega supplements, oral tetracycline and eye inserts. On the basis of distribution channel, the dry eye disease market is categorized into hospital pharmacies, independent pharmacies & drug stores and online pharmacies.

Global Dry Eye Disease Market: Regional Outlook

On the basis of geography, the dry eye disease market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America comprises the U.S. and Canada. Europe comprises Germany, France, U.K., Spain, Italy and Rest of Europe. Asia-Pacific comprises China, India, Japan, Australia & New Zealand and Rest of Asia Pacific. Latin America comprises Brazil, Mexico and Rest of Latin America. Middle East & Africa comprises of GCC Countries, South Africa and Rest of Middle East & Africa.

Global Dry Eye Disease Market: Competitive Outlook

The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the dry eye disease market. The report also profiles major players in the dry eye disease market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Santen Pharmaceutical Co., Ltd., Novartis AG, Valeant Pharmaceuticals International, Inc., Allergan plc, Shire plc, TRB Chemedica International SA, Sun Pharmaceutical Industries Ltd., Senju Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd., Mitotech S.A. and FCI S.A.S.

The global dry eye disease market has been segmented as follows:

Global Dry Eye Disease Market, by Product

Artificial Tears
Anti-inflammatory Drugs
Cyclosporine
Corticosteroids
Lifitegrast
Punctal Plugs
Secretagogue
Others
Global Dry Eye Disease Market, by Distribution Channel

Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
Global Dry Eye Disease Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
Japan
China
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of MEA

  • Table 1 : Pipeline Analysis (1/5)
  • Table 2 : Pipeline Analysis (2/5)
  • Table 3 : Pipeline Analysis (3/5)
  • Table 4 : Pipeline Analysis (4/5)
  • Table 5 : Pipeline Analysis (5/5)
  • Table 6 : Global Dry Eye Disease Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
  • Table 7 : Global Dry Eye Disease Market Volume (Number of Units) Forecast, by Anti-inflammatory Drugs, 2015–2025
  • Table 8 : Global Dry Eye Disease Market Size (US$ Mn) Forecast, by Distribution channel, 2015–2025
  • Table 9 : Global Dry Eye Disease Market Size (US$ Mn) Forecast, by Region, 2015–2025
  • Table 10 : North America Dry Eye Disease Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
  • Table 11 : North America Dry Eye Disease Market Volume (Number of Units) Forecast, by Anti-inflammatory Drugs, 2015–2025
  • Table 12 : North America Dry Eye Disease Market Value (US$ Mn) Forecast, by Distribution channel, 2015–2025
  • Table 13 : North America Dry Eye Disease Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 14 : Europe Dry Eye Disease Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
  • Table 15 : Europe Dry Eye Disease Market Volume (Number of Units) Forecast, by Anti-inflammatory Drugs, 2015–2025
  • Table 16 : Europe Dry Eye Disease Market Value (US$ Mn) Forecast, by Distribution channel, 2015–2025
  • Table 17 : Europe Dry Eye Disease Market Value (US$ Mn) Forecast, by Country / Sub-region, 2015–2025
  • Table 18 : Asia Pacific Dry Eye Disease Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
  • Table 19 : Asia Pacific Dry Eye Disease Market Volume (Number of Units) Forecast, by Anti-inflammatory Drugs, 2015–2025
  • Table 20 : Asia Pacific Dry Eye Disease Market Value (US$ Mn) Forecast, by Distribution channel, 2015–2025
  • Table 21 : Asia Pacific Dry Eye Disease Market Value (US$ Mn) Forecast, by Country / Sub-region, 2015–2025
  • Table 22 : Latin America Dry Eye Disease Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
  • Table 23 : Latin America Dry Eye Disease Market Volume (Number of Units) Forecast, by Anti-inflammatory Drugs, 2015–2025
  • Table 24 : Latin America Dry Eye Disease Market Value (US$ Mn) Forecast, by Distribution channel, 2015–2025
  • Table 25 : Latin America Dry Eye Disease Market Value (US$ Mn) Forecast, by Country / Sub-region, 2015–2025
  • Table 26 : Middle East & Africa Dry Eye Disease Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
  • Table 27 : Middle East & Africa Dry Eye Disease Market Volume (Number of Units) Forecast, by Anti-inflammatory Drugs, 2015–2025
  • Table 28 : Middle East & Africa Dry Eye Disease Market Value (US$ Mn) Forecast, by Distribution channel, 2015–2025
  • Table 29 : Middle East & Africa Dry Eye Disease Market Value (US$ Mn) Forecast, by Country / Sub-region, 2015–2025
  • Figure 1 : Dry Eye Disease Market Size (US$ Mn), by Product Type, 2016 (A)
  • Figure 2 : Dry Eye Disease Market Revenue (%), by Distribution channel, 2016 (A)
  • Figure 3 : Global Dry Eye Disease Market Revenue (%), by Region, 2016 (A)
  • Figure 4 : Product Type Revenue (%), 2016
  • Figure 5 : Distribution Channel Revenue (%), 2016
  • Figure 6 : Global Dry Eye Disease Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 7 : Market Value Share, by Product Type (2016)
  • Figure 8 : Market Value Share, by Distribution Channel (2016)
  • Figure 9 : Market Value Share, by Region (2016)
  • Figure 10 : Global Prevalence Dry eye Disease
  • Figure 11 : Global Dry Eye Disease Market Value Share, by Product Type, 2016 and 2025
  • Figure 12 : Global Dry Eye Disease Market Attractiveness, by Product Type, 2017–2025
  • Figure 13 : Global Dry Eye Disease Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Artificial Tears, 2015–2025
  • Figure 14 : Global Dry Eye Disease Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anti-inflammatory Drugs, 2015–2025
  • Figure 15 : Global Dry Eye Disease Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Punctal Plugs, 2015–2025
  • Figure 16 : Global Dry Eye Disease Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Secretagogue, 2015–2025
  • Figure 17 : Global Dry Eye Disease Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
  • Figure 18 : Global Dry Eye Disease Market Value Share, by Distribution channel, 2016 and 2025
  • Figure 19 : Global Dry Eye Disease Market Attractiveness, by Distribution channel, 2017–2025
  • Figure 20 : Global Dry Eye Disease Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2015–2025
  • Figure 21 : Global Dry Eye Disease Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Independent Pharmacies & Drug Stores, 2015–2025
  • Figure 22 : Global Dry Eye Disease Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2015–2025
  • Figure 23 : Global Market Scenario
  • Figure 24 : Global Dry Eye Disease Market Value Share, by Region, 2016 and 2025
  • Figure 25 : Global Dry Eye Disease Market Attractiveness, by Region, 2017–2025
  • Figure 26 : North America Dry Eye Disease Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
  • Figure 27 : North America Dry Eye Disease Market Value Share Analysis, by Product Type, 2016 and 2025
  • Figure 28 : North America Dry Eye Disease Market Value Share Analysis, by Distribution channel, 2016 and 2025
  • Figure 29 : North America Dry Eye Disease Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 30 : North America Dry Eye Disease Market Attractiveness Analysis, by Country
  • Figure 31 : North America Dry Eye Disease Market Attractiveness Analysis, by Product Type
  • Figure 32 : North America Dry Eye Disease Market Attractiveness Analysis, by Distribution Channel
  • Figure 33 : Europe Dry Eye Disease Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
  • Figure 34 : Europe Dry Eye Disease Market Value Share Analysis, by Product Type, 2016 and 2025
  • Figure 35 : Europe Dry Eye Disease Market Value Share Analysis, by Distribution channel, 2016 and 2025
  • Figure 36 : Europe Dry Eye Disease Market Value Share Analysis, by Country / Sub-region, 2016 and 2025
  • Figure 37 : Europe Dry Eye Disease Market Attractiveness Analysis, by Country / Sub-region
  • Figure 38 : Europe Dry Eye Disease Market Attractiveness Analysis, by Product Type
  • Figure 39 : Europe Dry Eye Disease Market Attractiveness Analysis, by Distribution Channel
  • Figure 40 : Asia Pacific Dry Eye Disease Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
  • Figure 41 : Asia Pacific Dry Eye Disease Market Value Share Analysis, by Product Type, 2016 and 2025
  • Figure 42 : Asia Pacific Dry Eye Disease Market Value Share Analysis, by Distribution channel, 2016 and 2025
  • Figure 43 : Asia Pacific Dry Eye Disease Market Value Share Analysis, by Country / Sub-region, 2016 and 2025
  • Figure 44 : Asia Pacific Dry Eye Disease Market Attractiveness Analysis, by Country / Sub-region
  • Figure 45 : Asia Pacific Dry Eye Disease Market Attractiveness Analysis, by Product Type
  • Figure 46 : Asia Pacific Dry Eye Disease Market Attractiveness Analysis, by Distribution Channel
  • Figure 47 : Latin America Dry Eye Disease Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
  • Figure 48 : Latin America Dry Eye Disease Market Value Share Analysis, by Product Type, 2016 and 2025
  • Figure 49 : Latin America Dry Eye Disease Market Value Share Analysis, by Distribution channel, 2016 and 2025
  • Figure 50 : Latin America Dry Eye Disease Market Value Share Analysis, by Country / Sub-region, 2016 and 2025
  • Figure 51 : Latin America Dry Eye Disease Market Attractiveness Analysis, by Country / Sub-region
  • Figure 52 : Latin America Dry Eye Disease Market Attractiveness Analysis, by Product Type
  • Figure 53 : Latin America Dry Eye Disease Market Attractiveness Analysis, by Distribution Channel
  • Figure 54 : Middle East & Africa Dry Eye Disease Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
  • Figure 55 : Middle East & Africa Dry Eye Disease Market Value Share Analysis, by Product Type, 2016 and 2025
  • Figure 56 : Middle East & Africa Dry Eye Disease Market Value Share Analysis, by Distribution channel, 2016 and 2025
  • Figure 57 : Middle East & Africa Dry Eye Disease Market Value Share Analysis, by Country / Sub-region, 2016 and 2025
  • Figure 58 : Middle East & Africa Dry Eye Disease Market Attractiveness Analysis, by Country / Sub-region
  • Figure 59 : Middle East & Africa Dry Eye Disease Market Attractiveness Analysis, by Product Type
  • Figure 60 : Middle East & Africa Dry Eye Disease Market Attractiveness Analysis, by Distribution Channel
  • Figure 61 : Global Dry Eye Disease Market Share Analysis, by Company (2016)
  • Figure 62 : Santen Pharmaceutical Co., Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 63 : Santen Pharmaceutical Co., Ltd. R&D Expenditure (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 64 : Santen Pharmaceutical Co., Ltd. Breakdown of Net Sales, By Business Segment, 2016
  • Figure 65 : Novartis AG. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 66 : Novartis AG. R&D Expenditure (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 67 : Novartis AG. Breakdown of Net Sales, By Region, 2016
  • Figure 68 : Valeant Pharmaceuticals International, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 69 : Valeant Pharmaceuticals International, Inc. R&D Expenditure (US$ Mn) & Y-o-Y Growth (%), 2014–2016
  • Figure 70 : Valeant Pharmaceuticals International, Inc. Breakdown of Net Sales, By Business Segment, 2016
  • Figure 71 : Allergan plc Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 72 : Allergan plc R&D Expenditure (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 73 : Allergan plc Breakdown of Net Sales, By Business Segment, 2016
  • Figure 74 : Shire plc Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 75 : Shire plc R&D Expenditure (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 76 : Shire plc Breakdown of Net Sales, By Business Segment, 2016
  • Figure 77 : Sun Pharmaceutical Industries Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 78 : Sun Pharmaceutical Industries Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 79 : Sun Pharmaceutical Industries Ltd. Breakdown of Net Sales, By Region, 2016
  • Figure 80 : Senju Pharmaceutical Co., Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 81 : Senju Pharmaceutical Co., Ltd. Breakdown of Net Sales, By Business Segment, 2016
  • Figure 82 : Johnson & Johnson Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 83 : Johnson & Johnson R&D Expenditure (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 84 : Johnson & Johnson Breakdown of Net Sales, By Business Segment, 2016
  • Figure 85 : Otsuka Pharmaceutical Co., Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 86 : Otsuka Pharmaceutical Co., Ltd. R&D Expenditure (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 87 : Otsuka Pharmaceutical Co., Ltd. Breakdown of Net Sales, By Business Segment, 2016

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report